Decitabine: a historical review of the development of an epigenetic drug

ISSN： 0939-5555

Source： Annals of Hematology, Vol.84, Iss.1, 2005-12, pp. : 3-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Epigenetic therapy in MDS and acute AML: focus on decitabine

By Lübbert M. Wijermans P.

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients

By Wijermans P. Lübbert M. Verhoef G. Klimek V. Bosly A.

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 9-17

Springer Publishing Company

Access to resources Recommend Favorite

In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies

By Hackanson Björn Robbel Christian Wijermans Pierre Lübbert Michael

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite

Epigenetic Control of Gene Function in Enamel Development

Current Stem Cell Research & Therapy, Vol. 10, Iss. 5, 2015-01 ,pp. : 405-411

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Control of Gene Function in Enamel Development

Current Stem Cell Research & Therapy, Vol. 10, Iss. 5, 2015-08 ,pp. : 405-411

Bentham Science Publishers

Access to resources Recommend Favorite